Compare FMC Corp (FMC) vs Veritone Inc (VERI) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Veritone (VERI) stock trades at $1.04, down 2.8% on the day, reflecting significant fundamental challenges. The company reported a net loss of $111.73M on $92.19M revenue for 2025, with a negative net margin of -123.76%. Technical indicators are mixed but lean bearish, with moving averages signaling a downtrend. Recent news is dominated by multiple class-action lawsuits alleging securities fraud related to revenue overstatements, with a key deadline of July 20, 2026.

The outlook is clouded by severe financial losses, ongoing litigation, and negative profitability metrics. While a high gross margin of 68.52% and a low P/S ratio of 0.86 present a potential value case, the extreme negative ROE of -349.36% and substantial cash burn from operations pose critical risks. Analyst consensus is split, but the overwhelming negative sentiment from recent legal news creates a highly uncertain investment environment.